Compare Amylx Pharmaceuticals Inc (AMLX) vs Ryanair Holdings plc (RYAAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs Ryanair Holdings plc — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Ryanair Holdings plc trades at $60.03 (market cap $29.63B). The key difference: Ryanair Holdings plc is far larger — about 11.2× Amylx Pharmaceuticals Inc's market cap, and Ryanair Holdings plc pays a 1.51% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMLX | RYAAY | |
|---|---|---|
Market Cap | $2.64B | $29.63B |
Sector | Health | Industrials |
52-Week High | $24.19 | $73.82 |
52-Week Low | $7.82 | $53.24 |
Enterprise Value | $2.39B | $26.61B |
Dividend Yield | — | 1.51% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About Ryanair Holdings plc
Ryanair is the leading airline group by passenger numbers in Europe. The company employs a low-cost no-frills model to offer low fares to leisure customers on short-haul intra-European routes. In 2020, the most recent pre-pandemic fiscal year, the company carried 149 million passengers, utilizing a fleet of 467 Boeing 737 aircraft across its 1,800 routes. To keep costs low the company serves predominantly lower-cost secondary airports. The company generated sales of EUR 8.5 billion in fiscal 2020.
Read more on RYAAY →
